Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
NCT00376051Phase 4Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Sep 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of citalopram in frontotemporal dementia (FTD), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Neuropsychiatric Inventory at 6 weeks. Started Sep 2006; status: completed.
02
Drugs
citalopram
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT00376051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376051.